World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN (O) : 2455-3301
ISSN (P) : 3051-2557
IMPACT FACTOR: 7.533

ICV : 78.6

World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , Doi-Digital Online Identifier , ISSN National Centre , Zenodo Indexing , International CODEN Service, USA , 

Abstract

A CLINICAL STUDY TO EVALUATE THE EFFICACY OF CHANDANADICHURNA ANJANA ALONG WITH SHATAVARYADI CHURNA IN THE MANAGEMENT OF SHUKLA ARMA (NON- PROGRESSIVE PTERYGIUM)

*Dr. Amanveer Kour Chani, Prof. Dr. Ashu, Prof. Dr. Manoj Kumar

ABSTRACT

Shukla Arma (Non-progressive Pterygium) is one of the common ocular surface disorders described under Shuklagata Netraroga in Ayurveda. It is characterized by a slow-growing, white fibrovascular tissue extending from the conjunctiva towards the cornea. In modern ophthalmology, non-progressive pterygium is considered an atrophic fibrovascular degeneration of the conjunctiva, commonly associated with prolonged exposure to ultraviolet radiation, dust, wind, and dry climatic conditions. Although surgical excision remains the standard treatment, it is associated with a high recurrence rate and postoperative complications. Therefore, there is a need for a safe, effective, and non-surgical treatment modality. In Ayurveda, Shukla Arma can be managed by Lekhana Anjana when the lesion is small, thin, soft, and slowly progressive. Chandanadichurna Anjana, owing to its Lekhana and Kaphahara properties, along with Shatavaryadi Churna, which possesses Kaphahara, Rasayana, and Chakshushya properties, may provide an effective conservative management for Shukla Arma. Methodology: A prospective, open-label, single-arm clinical study will be conducted on 30 patients diagnosed with Shukla Arma (Non-progressive Pterygium) fulfilling the inclusion and exclusion criteria. All enrolled patients will receive Chandanadichurna Anjana (2 Shalaka once daily in the morning) along with Shatavaryadi Churna (6 g/day in divided doses with Ghrita and Madhu) for 30 days. Patients will be assessed before, during, and after treatment using subjective parameters including foreign body sensation, lacrimation, photophobia, and burning sensation, along with objective assessment of pterygium size using a Castroviejo caliper. Follow-up will be carried out on the 15th and 30th day.

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR